Ignite Creation Date:
2025-12-24 @ 1:12 PM
Ignite Modification Date:
2026-01-13 @ 12:57 AM
Study NCT ID:
NCT00738595
Status:
COMPLETED
Last Update Posted:
2009-05-29
First Post:
2008-08-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study to Evaluate the Effectiveness of EVT 302 in Smoking Cessation.
Sponsor:
Evotec Neurosciences GmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EVT 302/3009
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Dr S P Jones, VP Clinical Development
Old Organization:
Evotec